Neuland Laboratories Ltd Intimation Of S&P Global ESG Score 2022 |
18/02/2023 | bse |
Neuland Laboratories Ltd Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
17/02/2023 | bse |
Neuland Laboratories Ltd Audio Recording Of The Earnings Call Conducted On February 14 2023 |
14/02/2023 | bse |
Neuland Laboratories Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
14/02/2023 | bse |
Neuland Laboratories Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication |
14/02/2023 | bse |
Neuland Laboratories Ltd Change Of Name Of Risk Management Committee Of The Company |
13/02/2023 | bse |
Neuland Laboratories Ltd Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2022 Along With The Pr |
13/02/2023 | bse |
Neuland Laboratories Ltd Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December |
13/02/2023 | bse |
Neuland Laboratories Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
02/02/2023 | bse |
Neuland Laboratories Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
01/02/2023 | bse |